Biogen (BIIB) Tecfidera Sales Tracking $363-$365M for 4Q, says Deutsche Bank
Tweet Send to a Friend
Biogen (NASDAQ: BIIB) Tecfidera sales are tracking at $363-$365 million in Q4, according to Deutsche Bank, citing IMS data.
This article: 152 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 152 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
